Cargando…

Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs

This study evaluated the performance, acceptability, costs, and systems fit of three new cold chain devices in India: a second-generation ice-lined refrigerator (ILR), a solar direct drive (SDD) refrigerator, and a long-term passive device (LTPD). The evaluation was conducted over 15 months during 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sandeep, Mvundura, Mercy, Ray, Arindam, Haldar, Pradeep, Lennon, Pat, Muller, Nancy, Deb Roy, Arup, Rewaria, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509701/
https://www.ncbi.nlm.nih.gov/pubmed/37736536
http://dx.doi.org/10.1016/j.jvacx.2023.100385
_version_ 1785107801430818816
author Kumar, Sandeep
Mvundura, Mercy
Ray, Arindam
Haldar, Pradeep
Lennon, Pat
Muller, Nancy
Deb Roy, Arup
Rewaria, Sachin
author_facet Kumar, Sandeep
Mvundura, Mercy
Ray, Arindam
Haldar, Pradeep
Lennon, Pat
Muller, Nancy
Deb Roy, Arup
Rewaria, Sachin
author_sort Kumar, Sandeep
collection PubMed
description This study evaluated the performance, acceptability, costs, and systems fit of three new cold chain devices in India: a second-generation ice-lined refrigerator (ILR), a solar direct drive (SDD) refrigerator, and a long-term passive device (LTPD). The evaluation was conducted over 15 months during 2016–2017. Sites were selected for their diversity in climate, terrain, and grid electrical supply, and 31 cold chain devices were deployed, 1 to each site. Results showed that all three technologies maintained correct temperatures. The SDD refrigerators had no malfunctions, whilst the ILRs had at least one malfunction, mostly due to the printed circuit board’s sensitivity to the erratic power supply. The LTPD temperature display panel caused challenges initially that required replacement of all solar panels with lithium batteries. Yet the devices’ long holdovers helped ensure vaccine potency. One challenge, particularly with the ILRs and SDD refrigerators, was condensation. The passively cooled LTPD was valued in settings with smaller populations and unreliable or no power; however, some its features, including the need to condition ice blocks, made it challenging to operate. In addition, the acceptable temperature range for the LTPD, as for all passively cooled devices (greater than 0 °C and less than + 10 °C), was confusing for some health workers due to the decades-long emphasis on maintaining temperatures at + 2 °C to + 8 °C. The greatest system-related benefit was establishment of new cold chain points (CCPs) at locations with intermittent or no grid electricity, bringing immunisation services closer to hard-to-reach areas. A key limitation of all three devices was the inability to freeze ice packs, which are required for vaccine carriers, somewhat restricting the potential of these technologies to reach underserved populations. Moreover, establishing new CCPs added costs to the health system. Results from this study, including costing data, can help guide decision-making.
format Online
Article
Text
id pubmed-10509701
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105097012023-09-21 Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs Kumar, Sandeep Mvundura, Mercy Ray, Arindam Haldar, Pradeep Lennon, Pat Muller, Nancy Deb Roy, Arup Rewaria, Sachin Vaccine X Regular paper This study evaluated the performance, acceptability, costs, and systems fit of three new cold chain devices in India: a second-generation ice-lined refrigerator (ILR), a solar direct drive (SDD) refrigerator, and a long-term passive device (LTPD). The evaluation was conducted over 15 months during 2016–2017. Sites were selected for their diversity in climate, terrain, and grid electrical supply, and 31 cold chain devices were deployed, 1 to each site. Results showed that all three technologies maintained correct temperatures. The SDD refrigerators had no malfunctions, whilst the ILRs had at least one malfunction, mostly due to the printed circuit board’s sensitivity to the erratic power supply. The LTPD temperature display panel caused challenges initially that required replacement of all solar panels with lithium batteries. Yet the devices’ long holdovers helped ensure vaccine potency. One challenge, particularly with the ILRs and SDD refrigerators, was condensation. The passively cooled LTPD was valued in settings with smaller populations and unreliable or no power; however, some its features, including the need to condition ice blocks, made it challenging to operate. In addition, the acceptable temperature range for the LTPD, as for all passively cooled devices (greater than 0 °C and less than + 10 °C), was confusing for some health workers due to the decades-long emphasis on maintaining temperatures at + 2 °C to + 8 °C. The greatest system-related benefit was establishment of new cold chain points (CCPs) at locations with intermittent or no grid electricity, bringing immunisation services closer to hard-to-reach areas. A key limitation of all three devices was the inability to freeze ice packs, which are required for vaccine carriers, somewhat restricting the potential of these technologies to reach underserved populations. Moreover, establishing new CCPs added costs to the health system. Results from this study, including costing data, can help guide decision-making. Elsevier 2023-09-09 /pmc/articles/PMC10509701/ /pubmed/37736536 http://dx.doi.org/10.1016/j.jvacx.2023.100385 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular paper
Kumar, Sandeep
Mvundura, Mercy
Ray, Arindam
Haldar, Pradeep
Lennon, Pat
Muller, Nancy
Deb Roy, Arup
Rewaria, Sachin
Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs
title Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs
title_full Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs
title_fullStr Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs
title_full_unstemmed Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs
title_short Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costs
title_sort using new cold chain technologies to extend the vaccine cold chain in india: equipment performance, acceptability, systems fit, and costs
topic Regular paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509701/
https://www.ncbi.nlm.nih.gov/pubmed/37736536
http://dx.doi.org/10.1016/j.jvacx.2023.100385
work_keys_str_mv AT kumarsandeep usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT mvunduramercy usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT rayarindam usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT haldarpradeep usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT lennonpat usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT mullernancy usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT debroyarup usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts
AT rewariasachin usingnewcoldchaintechnologiestoextendthevaccinecoldchaininindiaequipmentperformanceacceptabilitysystemsfitandcosts